Tag Archives: Pediatric

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension

January 09, 2019 Share this content: Compared with healthy controls, all circulating platelet microvesicle subpopulations were significantly higher in untreated patients with PAH. In patients with pediatric pulmonary arterial hypertension (PAH), treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action, including the ability to inhibit circulating platelet microvesicles, according to the results of a… Read More »

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Pediatric leukemia 'super drug' could be developed in the coming years

Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes & Development. When a key protein responsible for leukemia, MLL, is stabilized, it slows the… Read More »